Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02231892 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT02231892 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 104 participants.
The verdict
NCT02231892, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
Background: \- Brain stimulation called repetitive transcranial magnetic stimulation (rTMS) may help people quit drugs. Researchers want to study how it works in healthy people first. Objective: \- To learn how to use rTMS to stimulate a brain area and to see how it affects brain function and thinking. Eligibility: \- Healthy, right-handed adults ages 18-55. Design: * Participants will be screened under another protocol. * They will have 4-11 study visits. * To start each visit, participants will have: * Physical exam. * Urine sample. * Breath tests for alcohol and cigarette smoke. * Questions about drug use and medications. * Visit 1: participants will have: * Single TMS pulses on the head to determine the right strength. They will wear earplugs and a cap. A wire coil will be placed on the head and an electrical current will go through it. Participants may perform simple muscle movements. They will repeat the procedures wearing another coil, in a helmet. * A few TMS pulses to show how rTMS feels. * A practice thinking task, maybe in a scanner that looks and sounds like a magnetic resonance imaging (MRI) scanner but does not take pictures. The MRI scanner is a metal cylinder surrounded by a strong magnetic field. The participant will lie on a table that slides in and out of the cylinder. * They may have a real MRI scan. * Visits 2-11, participants will: * Complete two questionnaires. * Get varied rTMS stimulation. Their heart rate and blood pressure may be monitored. * Have their vital signs checked. * They may perform thinking tasks at a computer, in a mock scanner, or in an MRI scanner. They may just lie still in the MRI scanner.
Interventions
- DEVICE TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2014-09-03 |
| Est. Completion | 2019-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02231892
The ClinicalTrials.gov registry entry for NCT02231892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TMS is the first listed.
NCT02231892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02231892 about?
NCT02231892 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study". Background: \- Brain stimulation called repetitive transcranial magnetic stimulation (rTMS) may help people quit drugs. Researchers want to study how it works in healthy people first. Objective: \- To learn how to use rTMS to stimulate a brain area and to see how it affects brain function and thi...
What is the current status of trial NCT02231892?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2014-09-03. Estimated completion is 2019-09-18.
What interventions are being tested in trial NCT02231892?
The interventions under investigation include: TMS (DEVICE).
Who is sponsoring clinical trial NCT02231892?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.